lunes, 4 de mayo de 2026
China’s strict new supply chain regulations could create massive problems for Western biopharma companies Just as it did with rare earth minerals, China is tightening control
https://www.statnews.com/2026/05/04/china-biotech-pharmaceuticals-supply-chain-regulations/
By Dennis KwokMay 4, 2026
Kwok is a former member of the Hong Kong Legislative Council and is principal at Fountainhead Global Partners.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario